Literature DB >> 23700865

[The role of vitamin D in the carcinogenesis of breast and ovarian cancer].

Małgorzata Walentowicz-Sadłecka1, Paweł Sadłecki, Paweł Walentowicz, Marek Grabiec.   

Abstract

The review evaluates the role of vitamin D in carcinogenesis. Based on ecological studies, the incidence of many cancers has been shown to be higher in northern countries, suggesting an association with latitude and solar radiation. Vitamin D produced in skin under the influence of sun exposure may play a protective role in the process leading to cancer. Vitamin D deficiency is now recognized as a pandemic, mainly due to lack of knowledge that sun exposure in moderation is the major source of vitamin D for most humans. After vitamin D was discovered to be the necessary element of nourishment to prevent rickets at the beginning of the twentieth century the theory concerning its role has evolved. It is now recognized that vitamin D, and particularly its active form 1.25 (OH)2D, is an important hormone playing a crucial role in human homeostasis. [1.25(OH)2D3 has been shown to inhibit cancer cell growth, induce cancer cell maturation, induce apoptosis, and decrease angiogenesis. Several studies suggested that living at higher geographical latitudes increased the risk of developing and dying of colon, prostate, breast and other cancers. People exposed to sunlight were noted to less likely develop cancer. Several studies evaluated circulating levels of 25(OH)D and its possible association with cancer. Case-control studies and laboratory tests have consistently demonstrated that vitamin D plays an important role in the prevention of breast cancer. Vitamin D supplementation is a much needed, low cost, effective, and safe intervention strategy for breast cancer prevention that should be implemented. It has been shown that vitamin D levels are lower in ovarian cancer patients. Low 25(OH) D concentration associated with lower overall survival rate might suggest for the important role of severe deficiency in more aggressive course of ovarian cancer. Testing for 25(OH)D in the standard procedure could help to find ovarian cancer patients with worse prognosis, who would benefit from special attention and supplementation. Vitamin D3 supplementation in moderate doses achieving 25(OH)D concentrations of 30-80 ng/ml, can be recommended as many benefits may be expected, including decreased risk of developing cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23700865     DOI: 10.17772/gp/1581

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  14 in total

1.  Vitamin D ameliorates hepatic ischemic/reperfusion injury in rats.

Authors:  Ansam Aly Seif; Doaa Mohamed Abdelwahed
Journal:  J Physiol Biochem       Date:  2014-04-22       Impact factor: 4.158

2.  The role of 1,25-dyhydroxyvitamin D3 in mouse liver ischemia reperfusion injury: regulation of autophagy through activation of MEK/ERK signaling and PTEN/PI3K/Akt/mTORC1 signaling.

Authors:  Jinghui Yang; Qi Chen; Shiyin Tian; Shaohua Song; Fang Liu; Quanxing Wang; Zhiren Fu
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

3.  Low 25-OH vitamin D levels at time of diagnosis and recurrence of ovarian cancer.

Authors:  Teresa Granato; Lucia Manganaro; Luca Petri; Maria Grazia Porpora; Valentina Viggiani; Antonio Angeloni; Emanuela Anastasi
Journal:  Tumour Biol       Date:  2015-09-09

4.  Association of Vitamin D Receptor Polymorphisms (FokI (Rs2228570), ApaI (Rs7975232), BsmI (Rs1544410), and TaqI (Rs731236)) with Gastric Cancer in a Kurdish Population from West of Iran.

Authors:  Zohreh Hoseinkhani; Mohsen Rastegari-Pouyani; Farahnaz Tajemiri; Kheirollah Yari; Kamran Mansouri
Journal:  Rep Biochem Mol Biol       Date:  2021-01

5.  Cardiac tissue oxidative stress and inflammation after vitamin D administrations in high fat- diet induced obese rats.

Authors:  Mahdieh Abbasalizad Farhangi; Ghazaleh Nameni; Ghazaleh Hajiluian; Mehran Mesgari-Abbasi
Journal:  BMC Cardiovasc Disord       Date:  2017-06-19       Impact factor: 2.298

6.  Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.

Authors:  Jue-Sheng Ong; Gabriel Cuellar-Partida; Yi Lu; Peter A Fasching; Alexander Hein; Stefanie Burghaus; Matthias W Beckmann; Diether Lambrechts; Els Van Nieuwenhuysen; Ignace Vergote; Adriaan Vanderstichele; Jennifer Anne Doherty; Mary Anne Rossing; Jenny Chang-Claude; Ursula Eilber; Anja Rudolph; Shan Wang-Gohrke; Marc T Goodman; Natalia Bogdanova; Thilo Dörk; Matthias Dürst; Peter Hillemanns; Ingo B Runnebaum; Natalia Antonenkova; Ralf Butzow; Arto Leminen; Heli Nevanlinna; Liisa M Pelttari; Robert P Edwards; Joseph L Kelley; Francesmary Modugno; Kirsten B Moysich; Roberta B Ness; Rikki Cannioto; Estrid Høgdall; Claus K Høgdall; Allan Jensen; Graham G Giles; Fiona Bruinsma; Susanne K Kjaer; Michelle At Hildebrandt; Dong Liang; Karen H Lu; Xifeng Wu; Maria Bisogna; Fanny Dao; Douglas A Levine; Daniel W Cramer; Kathryn L Terry; Shelley S Tworoger; Meir Stampfer; Stacey Missmer; Line Bjorge; Helga B Salvesen; Reidun K Kopperud; Katharina Bischof; Katja Kh Aben; Lambertus A Kiemeney; Leon Fag Massuger; Angela Brooks-Wilson; Sara H Olson; Valerie McGuire; Joseph H Rothstein; Weiva Sieh; Alice S Whittemore; Linda S Cook; Nhu D Le; C Blake Gilks; Jacek Gronwald; Anna Jakubowska; Jan Lubiński; Tomasz Kluz; Honglin Song; Jonathan P Tyrer; Nicolas Wentzensen; Louise Brinton; Britton Trabert; Jolanta Lissowska; John R McLaughlin; Steven A Narod; Catherine Phelan; Hoda Anton-Culver; Argyrios Ziogas; Diana Eccles; Ian Campbell; Simon A Gayther; Aleksandra Gentry-Maharaj; Usha Menon; Susan J Ramus; Anna H Wu; Agnieszka Dansonka-Mieszkowska; Jolanta Kupryjanczyk; Agnieszka Timorek; Lukasz Szafron; Julie M Cunningham; Brooke L Fridley; Stacey J Winham; Elisa V Bandera; Elizabeth M Poole; Terry K Morgan; Harvey A Risch; Ellen L Goode; Joellen M Schildkraut; Celeste L Pearce; Andrew Berchuck; Paul Dp Pharoah; Georgia Chenevix-Trench; Puya Gharahkhani; Rachel E Neale; Penelope M Webb; Stuart MacGregor
Journal:  Int J Epidemiol       Date:  2016-09-04       Impact factor: 7.196

7.  Clinical implications of vitamin D deficiency.

Authors:  Beata Matyjaszek-Matuszek; Monika Lenart-Lipińska; Ewa Woźniakowska
Journal:  Prz Menopauzalny       Date:  2015-06-22

8.  Antiproliferative Activity of Double Point Modified Analogs of 1,25-Dihydroxyvitamin D₂ Against Human Malignant Melanoma Cell Lines.

Authors:  Anna Piotrowska; Justyna Wierzbicka; Sharmin Nadkarni; Geoffrey Brown; Andrzej Kutner; Michał A Żmijewski
Journal:  Int J Mol Sci       Date:  2016-01-08       Impact factor: 5.923

9.  Preschool diets in children from Piła, Poland, require urgent intervention as implied by high risk of nutrient inadequacies.

Authors:  Sylwia Merkiel; Wojciech Chalcarz
Journal:  J Health Popul Nutr       Date:  2016-04-19       Impact factor: 2.000

Review 10.  Vitamin D and VDR in Gynecological Cancers-A Systematic Review.

Authors:  Eileen Deuster; Udo Jeschke; Yao Ye; Sven Mahner; Bastian Czogalla
Journal:  Int J Mol Sci       Date:  2017-11-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.